WuXi NextCODE Raises $75 Million for Genomics Operations

WuXi NextCODE, the contract genomics arm of the WuXi AppTec Group, closed a $75 million Series B financing from the company's existing investors and partners. WuXi AppTech acquired NextCODE, which used the largely homogenous genomic profile of Iceland as a base, in early 2015 for $65 million. WuXi said the B round financing will underwrite consumer products in China. WuXi NextCODE has operations in Shanghai, Cambridge, Mass. and Reykjavik. More details.... Share this with colleagues: // //